Insmed (INSM) Interest Expenses (2010 - 2026)

Insmed's Interest Expenses history runs 17 years deep, the most recent figure standing at $20.1 million for Q1 2026.

• On a quarterly basis, Interest Expenses fell 6.89% year-over-year to $20.1 million in Q1 2026; TTM through Mar 2026 was $40.5 million, a 1.35% decrease from a year earlier, with the FY2025 full-year figure at $1.5 billion, up 29.44% from the prior year.
• Interest Expenses rose to $20.1 million in Q1 2026 per INSM's latest filing, from -$21.2 million in the prior quarter.
• Across five years, Interest Expenses topped out at $21.6 million in Q1 2025 and bottomed at -$22.8 million in Q4 2024.
• The 5-year median for Interest Expenses is $20.3 million (2023), against an average of $12.6 million.
• Across the five-year window, Interest Expenses soared 514.21% in 2023 and tumbled 209.68% in 2024, its largest moves.
• Year by year, Interest Expenses stood at $19.0 million in 2022, then rose by 9.37% to $20.8 million in 2023, then tumbled by 209.68% to -$22.8 million in 2024, then increased by 7.14% to -$21.2 million in 2025, then soared by 194.87% to $20.1 million in 2026.
• Per Business Quant, the three latest INSM Interest Expenses figures stand at $20.1 million (Q1 2026), -$21.2 million (Q4 2025), and $20.4 million (Q3 2025).